XNYS
BTI
Market cap119bUSD
Sep 11, Last price
55.24USD
1D
0.69%
1Q
-11.36%
Jan 2017
-1.94%
Name
British American Tobacco PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
British American Tobacco p.l.c. (BAT) operates as a global purveyor of tobacco and nicotine products. Its extensive product range encompasses both traditional offerings, such as combustible cigarettes and classic oral tobacco forms like snus and moist snuff, and a growing selection of next-generation nicotine products, including vapour devices, tobacco heating systems, and modern oral pouches. The company markets its diverse portfolio under prominent brand names like Kent, Dunhill, Lucky Strike, Pall Mall, Rothmans, Camel, Newport, and Natural American Spirit. Additionally, it features specific brands for its new categories, such as being Vapour, THP, and Modern Oral. These goods are distributed to consumers predominantly via retail outlets. Founded in 1902, British American Tobacco p.l.c. is centrally managed from its headquarters in London, United Kingdom.
Related entities
Subsidiaries (118)
NICOVENTURES BUSINESS CONSULTING (HONG KONG) CO., LIMITED
NICOVENTURES HOLDINGS LIMITED
NICOVENTURES RETAIL (UK) LIMITED
NICOVENTURES TRADING LIMITED
P.J. CARROLL & COMPANY LIMITED
PRECIS (1789) DENMARK A/S
PRECIS (1790) B.V.
PRECIS (1814) LIMITED
ROTHMANS (MIDDLE EAST) LIMITED
ROTHMANS FAR EAST B.V.
ROTHMANS INTERNATIONAL ENTERPRISES LIMITED
ROTHMANS OF PALL MALL LIMITED
ROTHMANS TOBACCO INVESTMENTS B.V.
ROTHMANS UK HOLDINGS B.V.
TDR DRUŠTVO SA OGRANIČENOM ODGOVORNOŠĆU ZA PROIZVODNJU DUHANSKIH PROIZVODA
THE RALEIGH INVESTMENT COMPANY LIMITED
TOBACCO IMPORTERS AND MANUFACTURERS SDN BHD
TOBACCO MANUFACTURERS (INDIA) LIMITED
UAB BRITISH AMERICAN TOBACCO LIETUVA
VINA-BAT JOINT VENTURE COMPANY
Key people
Non-Executive Chairman of the Board · since 2019
Jack Marie Henry David Bowles
Chief Executive Officer, Executive Director · since 2019
Ricardo Cesar de Almeida Cesar de Almeida Oberlander
President and Chief Executive Officer of Reynolds American Inc. · since 2018
J. Ben Stevens
Finance Director, Executive Director · since 2014
Luciano Comin
Regional Director - Americas and Sub Saharan Africa (AMSSA) · since 2019
Alan Davy
Director, Operations · since 2013
Hae In Kim
Director - Talent and Culture · since 2019
Paul Lageweg
Director - New Categories · since 2019
Guy Meldrum
Regional Director - Asia-Pacific and Middle East · since 2019
David O'Reilly
Group Scientific Director · since 2012
Johan Vandermeulen
Regional Director - Europe and North Africa · since 2019
Paul McCrory
Company Secretary · since 2017
Susan Jane Farr
Non-Executive Independent Director · since 2015
Jeremy S. G. Fowden
Non-Executive Independent Director · since 2019
Non-Executive Independent Director · since 2017
Savio Kwan
Non-Executive Independent Director · since 2014
Dimitri E. Panayotopoulos
Non-Executive Independent Director · since 2015
Headquarters & legal address
GLOBE HOUSE
4 TEMPLE PLACE
LONDON, LND WC2R 2PG
GB
4 TEMPLE PLACE
LONDON, LND WC2R 2PG
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||